Biovanta – Pharmaceuticals and Biotechnology industry

Advancing Global Health Through Scientific Innovation

Driving innovation in medicine through advanced research, precision science, and global pharmaceutical solutions.

Join Research, Advance Global Health Together

Discover how you can participate in clinical trials and contribute to future medical breakthroughs.

mRNA-X Platform

Advanced delivery system for mRNA-based vaccines and therapeutics with enhanced stability and targeting Nanoparticle-based drug carrier that improves .

NanoShield Encapsulation System

Advanced delivery system for mRNA-based vaccines and therapeutics with enhanced stability and targeting Nanoparticle-based drug carrier that improves .

AI-Predict Drug Finder™

Advanced delivery system for mRNA-based vaccines and therapeutics with enhanced stability and targeting Nanoparticle-based drug carrier that improves .

CRISPR-Cure Edit Suite

Advanced delivery system for mRNA-based vaccines and therapeutics with enhanced stability and targeting Nanoparticle-based drug carrier that improves .

Mapping Innovation Across The Global Landscape

Visualize our patent reach across key regions, ensuring worldwide protection and innovation leadership.

Neurogenix-11 Licensing Program

Open for regional licensing of our Phase II Alzheimer’s therapeutic candidate with strong early results.

AI-Predict™-11 Co-Development

Open for regional licensing of our Phase II Alzheimer’s therapeutic candidate with strong early results.

mRNA-X Platform Access Agreement

Open for regional licensing of our Phase II Alzheimer’s therapeutic candidate with strong early results.

Joint Oncology Research Initiative

Open for regional licensing of our Phase II Alzheimer’s therapeutic candidate with strong early results.

Partner With Us To Advance Healthcare

Explore exclusive licensing deals and strategic collaborations for global scientific and clinical breakthroughs.

Voices of Trust, Powered by Science

Hear real stories from partners, patients, and professionals who’ve experienced our innovation in action.